Abstract:Background: Oxylipins are biological lipids that have been implicated in inflammation. We previously found that certain oxylipins correlated with clinical manifestations in psoriatic arthritis (PsA) patients. Here, we compare oxylipin profiles in PsA patients and those with psoriasis (PsO) without inflammatory arthritis to identify oxylipins that associate with specific disease manifestations to better understand disease pathogenesis and identify new biomarkers. Methods: Consecutive patients with PsA (who met the CASPAR classification criteria for PsA) and PsO were recruited from the Rheumatology Outpatient Clinic. A thorough clinical examination was performed, including entheseal (Leeds enthesitis index (LEI)) and joint involvement (SJC/TJC 66/68). Patients were evaluated for pain and global disease activity on a visual analog scale (VAS) ranging from 0 to 100. This was followed by disease activity scores calculation: cDAPSA (Disease Activity Index for Psoriatic Arthritis) and Psoriasis Area and Severity Index (PASI). Serum oxylipins were determined by mass spectrometry and their association with clinical characteristics (PASI/LEI and cDAPSA) was analyzed using Metaboanalyst 4.0 and R version 3.6.1. Results: Twenty PsO (average age 52 [10.8], 55% males) and 19 PsA patients (average age 60.5 [11.4], 63.1% males) were included. PsO patients had an average body mass index (BMI) of 33.7 (6.84) and an average PASI of 3.8 (4.2). PsA patients had an average BMI of 31.9 (5.6), TJC of 9.3 (10.41), SJC of 3.7 (4.23), with an average cDAPSA of 23.3 (11.4). 63.1% of PsA patients had enthesitis (average LEI 2.2 [3]) and the same percentage had psoriasis (average PASI 3(5]). Sera were analyzed for oxylipin levels. PsO and PsA patients with higher PASI score (> 2.5) had significantly lower serum concentrations of pro-inflammatory oxylipins, most of them arachidonic acid derived (AA). Oxylipin profiling did not associate with cDAPSA. Interestingly, several AA-derived oxylipins (5,15 di-HETE (5S,15S-dihydroxy-6E,8Z,10Z,13E-eicosatetraenoic acid), 5-oxoETE (5-Oxo-eicosatetraenoic acid), PGE2 (prostaglandin E2), 11bPGE2 (11 beta prostaglandin D2), and LTB4 (leukotriene B4)) were significantly increased in PsA patients with enthesitis compared to those without. Conclusions: The AA-derived proinflammatory oxylipins were lower in both PsO and PsA patients with higher skin scores. Joint disease activity was not associated with the concentrations of oxylipins. Yet, enthesitis was associated with an increase of AA-derived pro-inflammatory oxylipins in PsA patients. Further studies are needed to determine whether oxylipin profiling can be a good biomarker of enthesitis in PsA patients.

The Expression of Oxidized Low Density Lipoprotein and Scavenger Receptor That Binds Phospha-Tidylserine and Oxidized Lipoprotein in Patients with Rheumatoid Arthritis

Oxidized low density lipoprotein promotes proliferation and mRNA expression of inflammatory factors in fibroblast like synoviocytes of rheumatoid arthritis

[Serum Levels of Several Chemokines in Patients with Rheumatoid Arthritis].

Expression of Interleukin-18, Il-18bp, and Il-18r in Serum, Synovial Fluid, and Synovial Tissue in Patients with Rheumatoid Arthritis

Clinical Lipidomics Analysis Reveals Biomarkers of Lipid Peroxidation in Serum from Patients with Rheumatoid Arthritis

Abnormal Characteristics of Plasma Lipid Levels in Patients with Rheumatoid Arthritis

Native, Oxidized Lipoprotein(a) and Lipoprotein(a) Immune Complex in Patients with Active and Inactive Rheumatoid Arthritis: Plasma Concentrations and Relationship to Inflammation.

Expression of RNATES,MCP-1 in serum and synovial fluid in patients with rheumatoid arthritis and its clinical significance

Native and Oxidized Lipoprotein(a) Levels in Patients with Rheumatoid Arthritis

Differences in oxylipin profile in psoriasis versus psoriatic arthritis

Expression of CD25 and CD69 on T Cells in Sera and Synovial Fluid from Patients with Rheumatoid Arthritis

High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis

Associations Between D3R Expression in Synovial Mast Cells and Disease Activity and Oxidant Status in Patients with Rheumatoid Arthritis

Low levels of pro-resolving lipid mediators lipoxin-A4, resolvin-D1 and resolvin-E1 in patients with rheumatoid arthritis

Analyzing the Level of Malondialdehyde-Modified Low-Density Lipoproteins and Its Immune Complexes in Patients with Rheumatoid Arthritis

Lipid Peroxidation and Detection of Pro-Inflammatory Variables in Rheumatoid Arthritis- A Comprehensive Analysis of Malondialdehyde and Isoprostanes in Synovial Fluids and SERA

Increased serum levels of β₂-GPI-Lp(a) complexes and their association with premature atherosclerosis in patients with rheumatoid arthritis.

Increased Expression of Siglec-1 on Peripheral Blood Monocytes and Its Role in Mononuclear Cell Reactivity to Autoantigen in Rheumatoid Arthritis.

[Association Between Systemic Inflammation and Autoimmunity Parameters and Plasma Lipid in Patients with Rheumatoid Arthritis].

High Density Lipoprotein Antioxidant Capacity and Subtype Distribution and Analysis of Paraoxonase-1 Activity in Patients with Systemic Lupus Erythematosus

Relationship Between the Lipidome Profile and Disease Activity in Patients with Rheumatoid Arthritis